Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)
Clinical trial NCT04057040 · COMPLETED
Trial details
- NCT number
- NCT04057040
- Sponsor
- Protagonist Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-01
- Primary completion
- 2023-02-14
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.